APA (7th ed.) Citation

GJ, H., OY, Z., P, G., DR, A., PJ, O., AE, R., . . . TM, W. (2026). Amivantamab for Recurrent or Metastatic Adenoid Cystic Carcinoma: A Phase 2 Nonrandomized Clinical Trial. JAMA otolaryngology-- head & neck surgery, 152(4), 376. https://doi.org/10.1001/jamaoto.2025.5404

Chicago Style (17th ed.) Citation

GJ, Hanna, et al. "Amivantamab for Recurrent or Metastatic Adenoid Cystic Carcinoma: A Phase 2 Nonrandomized Clinical Trial." JAMA Otolaryngology-- Head & Neck Surgery 152, no. 4 (2026): 376. https://doi.org/10.1001/jamaoto.2025.5404.

MLA (9th ed.) Citation

GJ, Hanna, et al. "Amivantamab for Recurrent or Metastatic Adenoid Cystic Carcinoma: A Phase 2 Nonrandomized Clinical Trial." JAMA Otolaryngology-- Head & Neck Surgery, vol. 152, no. 4, 2026, p. 376, https://doi.org/10.1001/jamaoto.2025.5404.